Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Late stage QFRET-based biochemical high throughput dose response assay to identify exosite inhibitors of ADAM17
Assay data:2 Active, 24 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
QFRET-based biochemical high throughput dose response assay to identify exosite inhibitors of ADAM17
Assay data:5 Active, 1 Activity ≤ 1 µM, 248 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
Counterscreen for exosite inhibitors of ADAM17: Fluorescence resonance energy transfer (FRET)-based biochemical high throughput dose response assay to identify inhibitors of ADAM10
Assay data:28 Active, 1 Activity ≤ 1 µM, 248 Tested
QFRET-based biochemical high throughput confirmation assay to identify exosite inhibitors of ADAM17
Assay data:1855 Active, 2872 Tested
Summary of the probe development effort to identify exosite inhibitors of ADAM17.
SummaryPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM17.
Assay data:3080 Active, 370276 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on